Empowered Funds LLC bought a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the 2nd quarter, Holdings Channel reports. The institutional investor bought 41,399 shares of the financial services provider’s stock, valued at approximately $6,900,000.
Several other large investors have also recently modified their holdings of MRSH. Headlands Technologies LLC bought a new stake in shares of Marsh & McLennan Companies during the second quarter valued at approximately $29,000. Solstein Capital LLC purchased a new position in shares of Marsh & McLennan Companies in the 4th quarter worth $25,000. SHP Wealth Management bought a new stake in shares of Marsh & McLennan Companies during the 4th quarter valued at about $26,000. KERR FINANCIAL PLANNING Corp bought a new stake in Marsh & McLennan Companies during the fourth quarter valued at approximately $27,000. Finally, Asset Dedication LLC purchased a new stake in shares of Marsh & McLennan Companies in the 1st quarter worth $25,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.
Analysts Set New Price Targets
MRSH has been the subject of several analyst reports. Citigroup lowered shares of Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 target price for the company. in a report on Wednesday, July 22nd. Morgan Stanley upped their price target on Marsh & McLennan Companies from $180.00 to $200.00 and gave the stock an “equal weight” rating in a research note on Wednesday, August 19th. Weiss Ratings upgraded shares of Marsh & McLennan Companies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, August 7th. Wells Fargo & Company upped their target price on shares of Marsh & McLennan Companies from $186.00 to $188.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 22nd. Finally, Cantor Fitzgerald boosted their price target on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Marsh & McLennan Companies presently has a consensus rating of “Hold” and an average price target of $203.50.
Marsh & McLennan Companies Price Performance
Shares of MRSH stock opened at $192.90 on Monday. The stock has a market capitalization of $92.05 billion, a P/E ratio of 23.58, a PEG ratio of 2.67 and a beta of 0.59. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.14 and a current ratio of 1.14. The company’s 50 day moving average is $182.75. Marsh & McLennan Companies, Inc. has a 1 year low of $156.60 and a 1 year high of $207.82.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last released its earnings results on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.89 by $0.07. Marsh & McLennan Companies had a return on equity of 32.67% and a net margin of 14.24%.The firm had revenue of $7.28 billion for the quarter. Marsh & McLennan Companies’s quarterly revenue was up 6.2% on a year-over-year basis. Equities research analysts expect that Marsh & McLennan Companies, Inc. will post 10.44 EPS for the current year.
Marsh & McLennan Companies Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Thursday, July 23rd were given a dividend of $0.99 per share. This represents a $3.96 annualized dividend and a dividend yield of 2.1%. This is a boost from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. The ex-dividend date was Thursday, July 23rd. Marsh & McLennan Companies’s dividend payout ratio (DPR) is presently 48.41%.
Insiders Place Their Bets
In other Marsh & McLennan Companies news, insider Martin South sold 7,100 shares of the company’s stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total value of $1,348,929.00. Following the transaction, the insider owned 16,632 shares of the company’s stock, valued at $3,159,913.68. This represents a 29.92% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Paul Beswick sold 713 shares of the stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $198.00, for a total value of $141,174.00. Following the completion of the sale, the senior vice president owned 16,376 shares in the company, valued at approximately $3,242,448. The trade was a 4.17% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 36,469 shares of company stock worth $6,291,345. Corporate insiders own 0.38% of the company’s stock.
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Recommended Stories
- Five stocks we like better than Marsh & McLennan Companies
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
